Sharmila Mehta

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head

Ross A. Abrams, Kathryn Winter, Howard Safran et al. · American Journal of Clinical Oncology · 2020 · 63 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery

Sharmila Mehta, Pinto Llerena Jose, A. H. MIRZA et al. · Diseases of the Esophagus · 2012 · 17 citations · Full text

Medicine, Oncology, Surgery +17

Results of the randomized phase II portion of NRG Oncology/RTOG 0848 evaluating the addition of erlotinib to adjuvant gemcitabine for patients with resected pancreatic head adenocarcinoma.

Howard Safran, Kathryn Winter, Ross A. Abrams et al. · Journal of Clinical Oncology · 2017 · 14 citations

Medicine, Oncology, Pharmacotherapy +16